ERTAPENEM
Generic: ERTAPENEM
Eugia US LLCManufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
ERTAPENEM SODIUMActive Substance
2018-06-25Original Approval
ERTAPENEM is FDA application ANDA209133, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
1,024 reports
2
MACULAR DEGENERATION
778 reports
3
OFF LABEL USE
410 reports
4
PYREXIA
366 reports
5
NAUSEA
301 reports
6
PAIN
289 reports
7
WEIGHT DECREASED
250 reports
8
MALAISE
233 reports
9
ANAEMIA
225 reports
10
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
223 reports